Hopefully, the optimised manufacturing process (which the company has talked about) for PBCAR19B has allowed them to increase the phenotype(s) without the need for a new IND application.
As for the strategies outlined in that (and other papers) for increasing efficacy will be looked at by them as they could easily be incorporated into future trials.
Recent DTIL News
- Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/17/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 11:15:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:15:12 AM
- Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/13/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 12:26:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 12:26:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 12:25:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 12:25:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:19:05 PM
- Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement • Business Wire • 05/08/2024 12:15:00 PM
- Precision BioSciences to Report First Quarter Results on May 13, 2024 • Business Wire • 05/07/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:26:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:26:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:26:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:25:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:25:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:25:02 PM
- Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency • Business Wire • 05/07/2024 12:30:00 PM
- Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024 • Business Wire • 05/01/2024 11:05:00 AM
- Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics • Business Wire • 04/16/2024 08:15:00 PM
- Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update • Business Wire • 03/27/2024 10:45:00 AM
- Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024 • Business Wire • 03/20/2024 08:30:00 PM
- Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy • Business Wire • 03/19/2024 11:00:00 AM
- Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency • Business Wire • 03/06/2024 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:00:25 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM